BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 21987183)

  • 1. Double tunnel technique for the LVAD driveline: improved management regarding driveline infections.
    Schibilsky D; Benk C; Haller C; Berchtold-Herz M; Siepe M; Beyersdorf F; Schlensak C
    J Artif Organs; 2012 Mar; 15(1):44-8. PubMed ID: 21987183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Left ventricle assist devices and driveline's infection incidence: a single-centre experience.
    Bejko J; Toto F; Gregori D; Gerosa G; Bottio T
    J Artif Organs; 2018 Mar; 21(1):52-60. PubMed ID: 28988400
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Low Incidence of Pump-Related Infections in Jarvik 2000 Ventricular Assist Device Recipients with a Subcostal Driveline Exit Site.
    Letsou GV; Anand J; Ogburn E; Shah RM; Ganapathy AV; Cohn WE; Loor G; Frazier OH
    Tex Heart Inst J; 2019 Jun; 46(3):179-182. PubMed ID: 31708699
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A simple device to secure ventricular assist device driveline and prevent exit-site infection.
    Baronetto A; Centofanti P; Attisani M; Ricci D; Mussa B; Devotini R; Simonato E; Rinaldi M
    Interact Cardiovasc Thorac Surg; 2014 Apr; 18(4):415-7. PubMed ID: 24431003
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Special Treatment and Wound Care of the Driveline Exit Site after Left Ventricular Assist Device Implantation.
    Menon AK; Baranski SK; Unterkofler J; Autschbach R; Moza AK; Goetzenich A; Tewarie L
    Thorac Cardiovasc Surg; 2015 Dec; 63(8):670-4. PubMed ID: 26177225
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Reduction of INCOR® driveline infection rate with silicone at the driveline exit site.
    Camboni D; Zerdzitzki M; Hirt S; Tandler R; Weyand M; Schmid C
    Interact Cardiovasc Thorac Surg; 2017 Feb; 24(2):222-228. PubMed ID: 27702831
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Late-onset driveline infections: the Achilles' heel of prolonged left ventricular assist device support.
    Zierer A; Melby SJ; Voeller RK; Guthrie TJ; Ewald GA; Shelton K; Pasque MK; Moon MR; Damiano RJ; Moazami N
    Ann Thorac Surg; 2007 Aug; 84(2):515-20. PubMed ID: 17643627
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel driveline route for prevention from driveline infection: Triple tunnel method.
    Yoshitake S; Kinoshita O; Nawata K; Hoshino Y; Itoda Y; Kimura M; Yamauchi H; Ono M
    J Cardiol; 2018 Oct; 72(4):363-366. PubMed ID: 29731190
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Driveline exit-site care protocols in patients with left ventricular assist devices: a systematic review.
    Koken ZO; Yalcin YC; van Netten D; de Bakker CC; van der Graaf M; Kervan U; Verkaik NJ; Caliskan K
    Eur J Cardiothorac Surg; 2021 Sep; 60(3):506-515. PubMed ID: 33963835
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Left ventricular assist device driveline infection and the frequency of dressing change in hospitalized patients.
    Wus L; Manning M; Entwistle JW
    Heart Lung; 2015; 44(3):225-9. PubMed ID: 25746483
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduce Driveline Trauma Through Stabilization and Exit Site Management: 30 Days Feasibility Results from the Multicenter RESIST Study.
    Stahovich M; Sundareswaran KS; Fox S; Hallinan W; Blood P; Chen L; Pamboukian SV; Chinn R; Farrar DJ; Pagani FD; Blue L
    ASAIO J; 2016; 62(3):240-5. PubMed ID: 27111738
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Prevention of percutaneous driveline infection after left ventricular assist device implantation: prophylactic antibiotics are not necessary.
    Stulak JM; Maltais S; Cowger J; Joyce LD; Daly RC; Park SJ; Aaronson KD; Pagani FD
    ASAIO J; 2013; 59(6):570-4. PubMed ID: 24172262
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Dynamics of bacterial pathogens at the driveline exit site in patients with ventricular assist devices: A prospective, observational, single-center cohort study.
    Pitton M; Valente LG; Oberhaensli S; Casanova C; Sendi P; Schnegg B; Jakob SM; Cameron DR; Que YA; Fürholz M
    J Heart Lung Transplant; 2023 Oct; 42(10):1445-1454. PubMed ID: 37245557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Stopping conventional showering decreases Pseudomonas infections in left ventricular assist device patients.
    Aburjania N; Sherazi S; Tchantchaleishvili V; Alexis JD; Hay CM
    Int J Artif Organs; 2017 Jun; 40(6):282-285. PubMed ID: 28430297
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention, treatment and outcomes of left ventricular assist device driveline infections. A single Center experience.
    Putnik S; Terzić D; Nestorović E; Karan R; Dobri M; Andrijasević V; Zlatkovic M; Kostić NK; Velinovic M; Ivanisevic D; Ristić M
    Ann Ital Chir; 2020; 91():8-15. PubMed ID: 32180572
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparing velour versus silicone interfaces at the driveline exit site of HeartMate II devices: infection rates, histopathology, and ultrastructural aspects.
    McCandless SP; Ledford ID; Mason NO; Alharethi R; Rasmusson BY; Budge D; Stoker SL; Clayson SE; Doty JR; Thomsen GE; Caine WT; Kfoury AG; Reid BB; Miller DV
    Cardiovasc Pathol; 2015; 24(2):71-5. PubMed ID: 25483742
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Long-Term Success With Driveline Exit Site Relocation for Deep Driveline Infection in Left Ventricular Assist Device Patients.
    Balsam LB; Jacoby A; Louie E; Levine JP
    Innovations (Phila); 2017; 12(6):440-445. PubMed ID: 29232297
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Role of Gallium-SPECT-CT in the Management of Patients With Ventricular Assist Device-Specific Percutaneous Driveline Infection.
    Kimura Y; Seguchi O; Mochizuki H; Iwasaki K; Toda K; Kumai Y; Kuroda K; Nakajima S; Tateishi E; Watanabe T; Matsumoto Y; Fukushima S; Kiso K; Yanase M; Fujita T; Kobayashi J; Fukushima N
    J Card Fail; 2019 Oct; 25(10):795-802. PubMed ID: 31454687
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Driveline angle is crucial for preventing driveline infection in patients with HeartMate II device.
    Matsumoto Y; Fukushima S; Shimahara Y; Yamashita K; Kawamoto N; Kuroda K; Seguchi O; Yanase M; Fukushima N; Shimizu H; Kobayashi J; Fujita T
    J Artif Organs; 2019 Mar; 22(1):37-43. PubMed ID: 30298341
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of an improved driveline management for HeartMate II and HeartMate 3 left ventricular assist devices.
    Mutsuga M; Okumura T; Morimoto R; Kondo T; Ito H; Terazawa S; Tokuda Y; Narita Y; Nishida K; Murohara T; Usui A
    Artif Organs; 2023 Feb; 47(2):387-395. PubMed ID: 36269680
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.